Literature DB >> 16920954

Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus.

Masahito Hashimoto1, Kazuki Tawaratsumida, Hiroyuki Kariya, Ai Kiyohara, Yasuo Suda, Fumiko Krikae, Teruo Kirikae, Friedrich Götz.   

Abstract

Lipoteichoic acid (LTA) derived from Staphylococcus aureus is reported to be a ligand of TLR2. However, we previously demonstrated that LTA fraction prepared from bacterial cells contains lipoproteins, which activate cells via TLR2. In this study, we investigated the immunobiological activity of LTA fraction obtained from S. aureus wild-type strain, lipoprotein diacylglycerol transferase deletion (delta lgt) mutant, which lacks palmitate-labeled lipoproteins, and its complemented strain and evaluated the activity of LTA molecule. LTA fraction was prepared by butanol extraction of the bacteria followed by hydrophobic interaction chromatography. Although all LTA fractions activated cells through TLR2, the LTA from delta lgt mutant was 100-fold less potent than those of wild-type and complemented strains. However, no significant structural difference in LTA was observed in NMR spectra. Further, alanylation of LTA molecule showed no effect in immunobiological activity. These results showed that not LTA molecule but lipoproteins are dominant immunobiologically active TLR2 ligand in S. aureus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920954     DOI: 10.4049/jimmunol.177.5.3162

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  94 in total

1.  SR-A, MARCO and TLRs differentially recognise selected surface proteins from Neisseria meningitidis: an example of fine specificity in microbial ligand recognition by innate immune receptors.

Authors:  Annette Plüddemann; Subhankar Mukhopadhyay; Marko Sankala; Silvana Savino; Mariagrazia Pizza; Rino Rappuoli; Karl Tryggvason; Siamon Gordon
Journal:  J Innate Immun       Date:  2008-09-11       Impact factor: 7.349

Review 2.  Novel targeted immunotherapy approaches for staphylococcal infection.

Authors:  Michael Otto
Journal:  Expert Opin Biol Ther       Date:  2010-07       Impact factor: 4.388

3.  Modulation of the local neutrophil response by a novel hyaluronic acid-binding peptide reduces bacterial burden during staphylococcal wound infection.

Authors:  Jerry C Lee; Jennifer L Greenwich; George G Zhanel; Xiaobing Han; Andrew Cumming; Laura Saward; Rachel M McLoughlin
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

4.  NOD2 stimulation by Staphylococcus aureus-derived peptidoglycan is boosted by Toll-like receptor 2 costimulation with lipoproteins in dendritic cells.

Authors:  Holger Schäffler; Dogan Doruk Demircioglu; Daniel Kühner; Sarah Menz; Annika Bender; Ingo B Autenrieth; Peggy Bodammer; Georg Lamprecht; Friedrich Götz; Julia-Stefanie Frick
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

Review 5.  Arterial Catheterization and Infection: Toll-like Receptors in Defense against Microorganisms and Therapeutic Implications.

Authors:  Zakary J Hambsch; Mitchell J Kerfeld; Daniel R Kirkpatrick; Dan M McEntire; Mark D Reisbig; Charles F Youngblood; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2015-08-14       Impact factor: 4.689

Review 6.  Understanding the significance of Staphylococcus epidermidis bacteremia in babies and children.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Curr Opin Infect Dis       Date:  2010-06       Impact factor: 4.915

7.  The virulence regulator Agr controls the staphylococcal capacity to activate human neutrophils via the formyl peptide receptor 2.

Authors:  Dorothee Kretschmer; Nele Nikola; Manuela Dürr; Michael Otto; Andreas Peschel
Journal:  J Innate Immun       Date:  2011-11-08       Impact factor: 7.349

8.  An important step in listeria lipoprotein research.

Authors:  Francisco García-del Portillo; Pascale Cossart
Journal:  J Bacteriol       Date:  2006-10-27       Impact factor: 3.490

Review 9.  CD36: implications in cardiovascular disease.

Authors:  Maria Febbraio; Roy L Silverstein
Journal:  Int J Biochem Cell Biol       Date:  2007-03-23       Impact factor: 5.085

10.  Structure-activity relationships of antimicrobial and lipoteichoic acid-sequestering properties in polyamine sulfonamides.

Authors:  Hemamali J Warshakoon; Mark R Burns; Sunil A David
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.